Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Recent studies with FXR agonist INT-747 highlight FXR's role in IBD

June 2, 2006

INKP-102 demonstrates superiority to Visicol in colonoscopy patients

June 1, 2006

VX-950 plus peg-interferon and ribavirin leads to undetectable hepatitis C virus

June 1, 2006

Methylnaltrexone shows efficacy in patients with opioid-induced constipation

June 1, 2006

PRECiSE trials detail safety and efficacy of certolizumab in Crohn's disease

June 1, 2006

ZK-156979 has therapeutic effect in experimental colitis

May 31, 2006

GW-427353 inhibits cholinergic contraction in human colon

May 31, 2006

Pro-Pharmaceuticals and Mount Sinai join forces on liver fibrosis research

May 30, 2006

Second U.S. phase III study of Zadaxin in HCV fails to meet primary endpoint

May 29, 2006

AST-120 studied in North America and Europe for fistulizing Crohn's disease

May 29, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...